Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Wize Pharma, Inc. (WIZP)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Wize Pharma, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Wize Pharma, Inc. since 2005.
The reporting company's ticker symbol is WIZP. The reporting company's CIK number is 1218683.
The total value of stock buying since 2005 is $2,042,384,653.
The total value of stock sales since 2005 is $60,062,500,000.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-04-21||Danenberg Noam (Chief Executive Officer)||Buy||125,000||1.00||125,000|
|2012-03-18||Regev Guy (Director)||Buy||32,072||63,677.00||2,042,248,744|
|2011-11-21||Rule Matthew (Other)||Sale||7,750,000||7,750.00||60,062,500,000|
Insider trading activities including stock purchases, stock sales, and option exercises of WIZP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Wize Pharma, Inc. (symbol WIZP, CIK number 1218683) see the Securities and Exchange Commission (SEC) website.